about
Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2Patterns of transmitted HIV drug resistance in Europe vary by risk groupTrends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicGeographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisCorrection: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-AnalysisNatural Products as Promising Therapeutics for Treatment of Influenza Disease.The global spread of HIV-1 subtype B epidemic.Molecular typing of the local HIV-1 epidemic in Serbia.Intravenous drug use - an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients.Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.Rubella immune status of neonates - a window towards seroprevalence among childbearing women.Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsHIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.Limited cross-border infections in patients newly diagnosed with HIV in EuropeTracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.Predicting HIV treatment response in Romania - Comment.The role and therapeutic potential of autophagy modulation in controlling virus-induced cell death.Primary resistance to integrase strand-transfer inhibitors in Europe.Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia.Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.Forensic application of phylogenetic analyses - Exploration of suspected HIV-1 transmission case.The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.mTOR-independent autophagy counteracts apoptosis in herpes simplex virus type 1-infected U251 glioma cells.Genetic detection of Dobrava-Belgrade hantavirus in the edible dormouse (Glis glis) in central Serbia.HBsAg as the antigen component of circulating immune complexes in HIV-infected patients.Antigen/antibody content of circulating immune complexes in HIV-infected patients.High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.Genetic analysis of Dobrava-Belgrade virus from western Serbia--a newly detected focus in the Balkan Peninsula.Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.Substitution rate and natural selection in parvovirus B19.Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics.Evidence of recombination in Tula virus strains from Serbia.Transmission of drug-resistant HIV-1 is stabilizing in Europe.International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology.Herpes simplex virus resistance to acyclovir in routine virological laboratory practice.p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.Hepatitis B Outbreak Among Men Who Have Sex with Men in the Autonomous Province of Vojvodina, Serbia.
P50
Q24652688-4E458C86-085D-4176-B6C2-21465E0FDC9FQ28537726-A3E30C98-70BC-49CE-BEAA-99D0C1E25081Q28540490-AA01C378-A8AD-4066-909B-8B9C93809C1AQ28545866-E1666164-2CAB-43AB-AEF0-346BCFF6A7F2Q28547717-0657FDD3-7CCE-4027-81B2-B93A24226AE0Q30379855-93FF1A4F-5B89-41F7-A894-402D884E9262Q30388926-5E04B613-7C05-4267-A474-FF653F5B2275Q30432346-8489F6B2-8EA2-4D96-95B9-60F8964D02D6Q33645965-0377D961-2AFA-4464-B1C8-A831406CAE6CQ33828355-BA32E76B-4AFE-48F2-A385-0941BAC708F9Q34469240-1C90C898-2CC6-4B99-A5B5-81768A950FDDQ36108127-BE3716C7-1EE1-4458-B508-2C2E0CED5AC4Q36367759-CB094BD1-5595-40D6-96DE-9E44C6A3C5CFQ36588672-50A5B385-4A7C-4B8D-9A5B-477DFB690C75Q36766901-E18FA7FD-40D1-4BF8-99E9-AE22B12CFB88Q37278724-936F34D3-FBDB-442F-BA8C-7B1A526A452FQ37334642-C13EA481-7194-4753-B95E-A3A742649B2BQ37441541-C15C03DA-9C1C-4806-874B-9596416996E9Q38152376-0CAD3827-C391-430E-807C-8E84AF8CBC38Q38424195-AA8D9EDF-FBBD-4D53-86E9-1DC4CFA94015Q38424625-94ABEF64-E750-46D4-AD9B-C2AE96B712E2Q38875822-41C1A30D-DA1D-48F7-88C7-C1DC69DFF7D1Q39006594-A75B45FD-2BC9-47F3-A6AC-991356FDFB57Q39064116-0D7FBF8C-EECE-45D6-9E4C-6C9FA0ACA510Q39112435-2B466156-BADA-4B01-9CBA-E85B5FB556F7Q39152750-1DCA0729-0729-450C-A1E6-1199DF39E7A7Q39204201-98F57C5C-A2AF-4AB7-AC72-CC12F4C006C9Q39486387-19D796BB-630A-4212-8CFA-777F9062AEEDQ39486392-E6AA2772-C01F-4D74-BA56-AB107C8D4910Q40108047-F4E54149-A707-456F-B667-F467BFD29468Q40205765-5B184434-97FC-461E-9F8C-C4AECF93A77BQ40396257-56F46AC2-CFAB-4C8D-8A97-92EB9CDD3CB9Q40489095-0CFA6668-8E40-4867-A07B-A9FC19A5C01EQ40751895-32C3E3D4-0A2E-404C-A0F7-6D65D91713A1Q42271977-0CC9BE43-B646-4BCF-9158-CCE2C0115735Q44591236-856141A7-28A3-41BA-B949-E5155E786DDFQ45349376-29C42FBF-A9A7-430D-8815-F54C3A4611EDQ45490211-8EC2CC8F-3517-4796-B7D3-520F4FC13938Q45781889-35B0605F-CD4D-4E48-9390-97D1CD0B3D44Q47638546-6FA01EED-580D-42A4-9ADF-A23E1EB4B1B9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maja Stanojevic
@ast
Maja Stanojevic
@en
Maja Stanojevic
@es
Maja Stanojevic
@nl
Maja Stanojevic
@sl
type
label
Maja Stanojevic
@ast
Maja Stanojevic
@en
Maja Stanojevic
@es
Maja Stanojevic
@nl
Maja Stanojevic
@sl
prefLabel
Maja Stanojevic
@ast
Maja Stanojevic
@en
Maja Stanojevic
@es
Maja Stanojevic
@nl
Maja Stanojevic
@sl
P106
P1153
57200768385
7006802893
P21
P31
P496
0000-0002-4643-4272